|
|
|
|
2-Amino-4-(nitroalkyl)-4H-chromene-3-carbonitriles as New Cytotoxic Agents
|
|
|
|
|
|
|
|
نویسنده
|
Zonouzi Afsaneh ,Mirzazadeh Roghieh ,Safavi Maliheh ,Kabudanian Ardestani Sussan ,Emami Saeed ,Foroumadi Alireza
|
|
منبع
|
iranian journal of pharmaceutical research - 2013 - دوره : 12 - شماره : 4 - صفحه:679 -685
|
|
چکیده
|
A series of 2-amino-4-(nitroalkyl)-4h-chromene-3-carbonitriles were synthesized by an efficient multicomponent reaction in aqueous media using dbu as a catalyst at room temperature. mild condition, environment friendly procedure and excellent yields are the main advantages of this procedure. the cytotoxic activity of target compounds were evaluated against three cancer cell lines mda-mb-231, mcf-7 and t47d in comparison with etoposide as reference drug. generally, all compounds showed good cell growth inhibitory activity with ic50 values less than 30 μg/ml. their activities were comparable or more potent than standard drug etoposide. the 6-bromo- derivatives 7e and 7f showed promising cytotoxic activity with ic50 values in the range of 3.46–18.76 μg/ml, being more potent than etoposide against all tested cell lines.
|
|
کلیدواژه
|
4H-chromenes; Benzopyran; DBU; One-pot synthesis; Cytotoxic activity.
|
|
آدرس
|
university of tehran, University College of Science, School of Chemistry, ایران, university of tehran, University College of Science, School of Chemistry, ایران, tehran university of medical sciences tums, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, ایران, university of tehran, Institute of Biochemistry and Biophysics, Department of Biochemistry, ایران, mazandaran university of medical sciences, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Department of Medicinal Chemistry, ایران, tehran university of medical sciences tums, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Drug Design and Development Research Center, ایران
|
|
پست الکترونیکی
|
aforoumadi@yahoo.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|